- Home
- AZI vs NXTC Comparison
AZI vs NXTC Comparison
Compare AZI & NXTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AZI
- NXTC
- Stock Information
- Founded
- AZI 2010
- NXTC 2015
- Country
- AZI China
- NXTC United States
- Employees
- AZI N/A
- NXTC N/A
- Industry
- AZI
- NXTC Biotechnology: Pharmaceutical Preparations
- Sector
- AZI
- NXTC Health Care
- Exchange
- AZI Nasdaq
- NXTC Nasdaq
- Market Cap
- AZI 25.6M
- NXTC 24.6M
- IPO Year
- AZI 2024
- NXTC 2019
- Fundamental
- Price
- AZI $0.08
- NXTC $8.71
- Analyst Decision
- AZI
- NXTC Strong Buy
- Analyst Count
- AZI 0
- NXTC 3
- Target Price
- AZI N/A
- NXTC $23.00
- AVG Volume (30 Days)
- AZI 30.7M
- NXTC 85.8K
- Earning Date
- AZI 01-01-0001
- NXTC 11-05-2025
- Dividend Yield
- AZI N/A
- NXTC N/A
- EPS Growth
- AZI N/A
- NXTC N/A
- EPS
- AZI N/A
- NXTC N/A
- Revenue
- AZI $156,466,000.00
- NXTC N/A
- Revenue This Year
- AZI N/A
- NXTC N/A
- Revenue Next Year
- AZI N/A
- NXTC N/A
- P/E Ratio
- AZI N/A
- NXTC N/A
- Revenue Growth
- AZI 32.90
- NXTC N/A
- 52 Week Low
- AZI $0.08
- NXTC $2.69
- 52 Week High
- AZI $3.20
- NXTC $19.20
- Technical
- Relative Strength Index (RSI)
- AZI 23.00
- NXTC 46.50
- Support Level
- AZI $0.08
- NXTC $8.51
- Resistance Level
- AZI $0.15
- NXTC $10.56
- Average True Range (ATR)
- AZI 0.02
- NXTC 1.23
- MACD
- AZI -0.00
- NXTC -0.36
- Stochastic Oscillator
- AZI 5.96
- NXTC 1.93
About AZI Autozi Internet Technology (Global) Ltd. Class A Ordinary Shares
Autozi Internet Technology (Global) Ltd provides high-quality, affordable, and professional one-stop automotive products and services through online and offline channels in China. Leveraging its online supply chain cloud platform, SaaS platforms, and the network of MBS stores, It has established an ecosystem of lifecycle automotive services by connecting automotive manufacturers, auto parts manufacturers, and insurance companies with MBS stores and various automotive owners. Its business segments include new car sales, auto parts and auto accessories sales, and automotive insurance-related services. The majority of revenue is from the new car sales segment, and auto parts & auto accessories sales.
About NXTC NextCure Inc.
NextCure Inc is a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. The company's product candidates include; NC410 a fusion protein of LAIR-2, a fusion protein that, in combination with pembrolizumab, demonstrated early evidence of clinical activity in colorectal (CRC) and ovarian cancers, and LNCB74, an ADC that is directed to B7-H4, a clinically validated cancer target. The company is also seeking a partner for its other clinical programs such as NC525 and NC318 and its preclinical non-oncology programs NC605, for chronic bone diseases and NC181, for Alzheimer's disease.